Emcure Pharmaceuticals Ltd Share Price
(EMCURE)
₹927.7▲0.23%
as on 04:01PM, 13 Mar 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -3.36 % |
3 Month Return | -34.15 % |
1 Year Return | -31.74 % |
Market Stats | |
Previous Close | ₹925.55 |
Open | ₹931.00 |
Volume | 82.30K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹17,573.59Cr |
P/E Ratio
28.4
PEG Ratio
2.47
Market Cap
₹17,573.59 Cr
P/B Ratio
0EPS
0Dividend Yield
0Sector
Pharmaceuticals
ROE
8.52
based on 3 analysts
66.67%
Buy
33.33%
Hold
0.00%
Sell
Based on 3 analysts offering long term price targets for Emcure Pharmaceuticals Ltd. An average target of ₹1535
Source: S&P Global Market Intelligence
Emcure Pharmaceuticals Ltd price forecast by 3 analysts
Upside of65.46%
High
₹1650
Target
₹1535.00
Low
₹1440
Emcure Pharmaceuticals Ltd target price ₹1535, a slight upside of 65.46% compared to current price of ₹927.7. According to 3 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Emcure Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2027:0
Forecast
Actual
Including amortisation and stock based compensations
Emcure Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2027:0
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Emcure Pharmaceuticals Ltd
Emcure Pharmaceuticals Receives USFDA Observations - 26 Feb, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 15.05% to 15.14% in Dec 2024 quarter
FII Holding Up
Foreign Institutions have increased holdings from 2.91% to 3.05% in Dec 2024 quarter
Price Dip
In the last 1 year, EMCURE stock has moved down by -31.7%
Promoter Holding Down
Promoters have decreased holdings from 78.08% to 77.94% in Dec 2024 quarter
MF Holding Down
Mutual Funds have decreased holdings from 3.30% to 3.10% in Dec 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 77.94% | ||
Foreign Institutions | 3.05% | 4.85 | |
Mutual Funds | 3.1% | ||
Retail Investors | 15.14% | 0.61 | |
Others | 0.77% | 16.61 |
Emcure Pharmaceuticals Ltd in the last 5 years
Lowest (28.34x)
March 12, 2025
Today (28.40x)
March 13, 2025
Industry (50.82x)
March 13, 2025
Highest (53.98x)
September 18, 2024
Emcure Pharmaceuticals Ltd’s net profit jumped 35.5% since last year same period to ₹153.72Cr in the Q3 2024-2025. On a quarterly growth basis, Emcure Pharmaceuticals Ltd has generated -21% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Emcure Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹17,573.59 Cr | -6.35% | 0.73 | ₹527 Cr | ₹6,658 Cr | |
BUY | ₹8,934.15 Cr | 26.69% | 0.62 | ₹48 Cr | ₹717 Cr | |
NA | ₹1,228.75 Cr | -7.69% | 0.62 | ₹57 Cr | ₹398 Cr | |
NA | ₹2,161.57 Cr | 88.29% | 0.56 | -₹15 Cr | ₹180 Cr | |
NA | ₹96.63 Cr | -9.28% | 0.64 | ₹9 Cr | ₹131 Cr |
Organisation | Emcure Pharmaceuticals Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Emcure Pharmaceuticals Ltd share price today stands at ₹927.7, Open: ₹931, Previous Close: ₹925.55, High: ₹944.05, Low: ₹916.75, 52 Week High: ₹1580, 52 Week Low: ₹916.75.
Emcure Pharmaceuticals Ltd is listed on NSE
Emcure Pharmaceuticals Ltd is listed on BSE
Today's traded volume of Emcure Pharmaceuticals Ltd(EMCURE) is 82.30K.
Today's market capitalisation of Emcure Pharmaceuticals Ltd(EMCURE) is ₹17573.59Cr.
Emcure Pharmaceuticals Ltd (EMCURE) share price is ₹927.7. It is down -41.28% from its 52 Week High price of ₹1580
Emcure Pharmaceuticals Ltd (EMCURE) share price is ₹927.7. It is up 1.19% from its 52 Week Low price of ₹916.75
PE Ratio of Emcure Pharmaceuticals Ltd is 28.4
PE ratio = Emcure Pharmaceuticals Ltd Market price per share / Emcure Pharmaceuticals Ltd Earnings per share